Hofseth BioCare ASA (OSL:HBC)
Norway · Delayed Price · Currency is NOK 2.070
+0.070 (3.50%)
At close: Oct 23, 2025
Hofseth BioCare ASA Revenue
Hofseth BioCare ASA had revenue of 68.44M NOK in the quarter ending June 30, 2025, a decrease of -14.88%. This brings the company's revenue in the last twelve months to 262.08M, up 13.91% year-over-year. In the year 2024, Hofseth BioCare ASA had annual revenue of 265.54M with 21.52% growth.
Revenue (ttm)
262.08M
Revenue Growth
+13.91%
P/S Ratio
3.23
Revenue / Employee
3.49M
Employees
78
Market Cap
846.83M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 265.54M | 47.03M | 21.52% |
| Dec 31, 2023 | 218.51M | 98.06M | 81.42% |
| Dec 31, 2022 | 120.45M | 32.83M | 37.47% |
| Dec 31, 2021 | 87.62M | 18.36M | 26.52% |
| Dec 31, 2020 | 69.25M | 1.47M | 2.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orkla ASA | 71.83B |
| Mowi ASA | 67.57B |
| Austevoll Seafood ASA | 38.24B |
| Lerøy Seafood Group ASA | 33.14B |
| SalMar ASA | 25.03B |
| Europris ASA | 14.36B |
| P/F Bakkafrost | 10.41B |
| Grieg Seafood ASA | 7.76B |
Hofseth BioCare ASA News
- 5 weeks ago - Hofseth Biocare ASA: AECORBIO SECURES A FURTHER $1.5M AT A $30M VALUATION FOR ONGOING FT-002A PEPTIDE DEVELOPMENT IN PROSTATE CANCER - GlobeNewsWire
- 6 weeks ago - Hofseth Biocare ASA: ProGo, the world's first consumer health GLP-1 & GIP receptor agonist with muscle mass protection via inhibition of Myostatin and Activin A pathways - GlobeNewsWire
- 7 weeks ago - Hofseth Biocare ASA: HBC onboards former Head of Nestle Health Science Asia, Oceania, Middle East and Africa Region, Paul Bruhn - GlobeNewsWire
- 2 months ago - Hofseth Biocare ASA: SECOND QUARTER 2025 FINANCIAL REPORT - GlobeNewsWire
- 3 months ago - Hofseth Biocare ASA: HBC's ProGo® has won Ingredient of the Year for Healthy Aging at the prestigious Nutraingredients USA awards ceremony in Chicago - Benzinga
- 3 months ago - Hofseth Biocare ASA: HBC's ProGo® has won Ingredient of the Year for Healthy Aging at the prestigious Nutraingredients USA awards ceremony in Chicago - GlobeNewsWire
- 5 months ago - Hofseth Biocare ASA: Annual General Meeting completed - GlobeNewsWire
- 5 months ago - Hofseth Biocare ASA: FIRST QUARTER 2025 FINANCIAL REPORT - GlobeNewsWire